Yozma

News

  • Admin
  • Jul 23 2025

[Press Release]

Alpha Tau’s Combination Therapy with Alpha DaRT and Pembrolizumab Presented at IAOO2025

https://www.linkedin.com/posts/sharett-oncology-institute_headandneckcancer-hnscc-alphadart-activity-7352977921461895169-ouLV?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFu5SeoB2RmNWQIbLxEl1H1ubGVq-1hqUzE
Previous
365mc and Raziel Therapeutics Announce Strategic Collaboration to Accelerate Development of RZL-012 in South Korea Jul 15 2025
Next
ULTRA RED Joins Black Hat USA 2025 to Showcase Its Validation-First CTEM Approach Jul 23 2025
List